ISPC

iSpecimen Inc
NASDAQHEALTHCAREDIAGNOSTICS & RESEARCH

Key Statistics

Market Cap
$3.45M
P/E Ratio
EPS
$-310.98
Beta
1.63
52W High
$103.20
52W Low
$2.26
50-Day MA
$3.59
200-Day MA
$15.38
Dividend Yield
Profit Margin
0.00%
Forward P/E
PEG Ratio

About iSpecimen Inc

iSpecimen, Inc. provides technology that connects life science researchers in need of human biofluids, tissues and living cells for their research with biospecimens available from healthcare provider organizations globally. The company is headquartered in Lexington, Massachusetts.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$1.03M
Gross Profit (TTM)-304,522
EBITDA$-9.68M
Operating Margin-1627.00%
Return on Equity-895.00%
Return on Assets-91.80%
Revenue/Share (TTM)$5.53
Book Value$1.10
Price-to-Book4.64
Price-to-Sales (TTM)3.36
EV/Revenue1.183
EV/EBITDA0.43
Quarterly Earnings Growth (YoY)0.00%
Quarterly Revenue Growth (YoY)-85.20%
Shares Outstanding$1.44M
Float$1.44M
% Insiders0.07%
% Institutions0.93%

Historical Volatility

HV 10-Day
73.35%
HV 20-Day
66.57%
HV 30-Day
66.80%
HV 60-Day
107.41%
HV Rank

Volatility is currently expanding

Latest News

E.F. Hutton & Co. Serves as Exclusive Placement Agent on iSpecimen Inc. $2.5 Million Private Placement

NEW YORK, May 12, 2026 (GLOBE NEWSWIRE) -- E.F. Hutton & Co. (“E.F. Hutton”), an investment banking and financial advisory firm headquartered in New York City, today announced that it acted as the exclusive placement agent in connection with a $2.5 million private placement for iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers.

GlobeNewsWire5/12/2026Neutral
iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement

May 8, 2026 WOBURN, Mass., May 08, 2026 (GLOBE NEWSWIRE) -- iSpecimen Inc. (Nasdaq: ISPC) (“iSpecimen” or the “Company”), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, today announced that it has priced a private placement with accredited investors for aggregate gross proceeds of approximately $2.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company.

GlobeNewsWire5/9/2026Neutral
iSpecimen Announces 1-for-40 Reverse Stock Split

Woburn, Massachusetts--(Newsfile Corp. - April 24, 2026) - iSpecimen Inc. (NASDAQ: ISPC) ("iSpecimen" or the "Company"), an online global marketplace that connects scientists requiring biospecimens for medical research with a network of healthcare specimen providers, announced today that it will effect a reverse stock split of its issued and outstanding shares of common stock, par value $0.0001 per share, as well as any shares of common stock held by the Company in treasury, at a ratio of 1-for-40. The reverse stock split will become effective at 4:30 p.m.

Newsfile Corp4/24/2026Neutral
iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally. By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing.

Newsfile Corp4/9/2026Neutral

More HEALTHCARE Stocks

Data last updated: 7/9/2026